pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

181 catalysts · 123 device recall · 20 device 510k · 17 approval · 12 recall · 9 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-29×to 2025-10-29×clear all
type
  • device recall123
  • device 510k20
  • approval17
  • recall12
  • device pma9
therapy area

no tagged catalysts yet

Week of Oct 27, 2025

50
›Oct 29, 2025approval290d agoKETALAR (KETAMINE HYDROCHLORIDE) — FDA approvalPar Pharmaceutical Inc

Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Oct 29, 2025approval290d agoNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE (HYDROCORTISONE) — FDA approvalET-800

Sponsor: AMNEAL. Form: SOLUTION/DROPS. Route: OTIC

full page →ET-800 →fda approvals ↗
›Oct 29, 2025approval290d agoJUBBONTI (DENOSUMAB-BBDZ) — FDA approvalJUBBONTI

Sponsor: SANDOZ INC. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →JUBBONTI →fda approvals ↗
›Oct 29, 2025approval290d agoHIBICLENS (CHLORHEXIDINE GLUCONATE) — FDA approvalCoorg Instituite of Dental Sciences

Sponsor: MOLNLYCKE HLTH. Form: SOLUTION. Route: TOPICAL

full page →fda approvals ↗
›Oct 29, 2025approval290d agoDENOSUMAB-DSSB — FDA approvaldenosumab biosimilar

Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →denosumab biosimilar →fda approvals ↗
›Oct 29, 2025approval290d agoCONEXXENCE (DENOSUMAB-BNHT) — FDA approvalCONEXXENCE

Sponsor: FRESENIUS KABI USA LLC. Form: INJECTION

full page →CONEXXENCE →fda approvals ↗
›Oct 29, 2025approval290d agoOSENVELT (DENOSUMAB-BMWO) — FDA approvalOSENVELT

Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INJECTION

full page →OSENVELT →fda approvals ↗
›Oct 29, 2025approval290d agoOSVYRTI (denosumab-desu) — FDA approvalOSVYRTI

Sponsor: ACCORD BIOPHARMA INC.. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →OSVYRTI →fda approvals ↗
›Oct 29, 2025approval290d agoPOSACONAZOLE — FDA approvalPOSACONAZOLE

Sponsor: MSN. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →POSACONAZOLE →fda approvals ↗
›Oct 29, 2025approval290d agoPIFELTRO (DORAVIRINE) — FDA approvaldoravirine

Sponsor: MSD MERCK CO. Form: TABLET. Route: ORAL

full page →doravirine →fda approvals ↗
›Oct 29, 2025approval290d agoDELSTRIGO (DORAVIRINE) — FDA approval(doravirine + lamivudine + tenofovir disoproxil fumarate)

Sponsor: MSD MERCK CO. Form: TABLET. Route: ORAL

full page →(doravirine + lamivudine + tenofovir disoproxil fumarate) →fda approvals ↗
›Oct 29, 2025approval290d agoAUKELSO (DENOSUMAB-KYQQ) — FDA approvalAUKELSO

Sponsor: BIOCON BIOLOGICS INC. Form: INJECTABLE. Route: INJECTION

full page →AUKELSO →fda approvals ↗
›Oct 29, 2025approval290d agoENOBY (DENOSUMAB-QBDE) — FDA approvalENOBY

Sponsor: HIKMA PHARMACEUTICALS USA INC. Form: SOLUTION. Route: INJECTION

full page →ENOBY →fda approvals ↗
›Oct 29, 2025approval290d agoBILPREVDA (DENOSUMAB-NXXP) — FDA approvalBILPREVDA

Sponsor: SHANGHAI HENLIUS BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →BILPREVDA →fda approvals ↗
›Oct 29, 2025approval290d agoVARENICLINE TARTRATE — FDA approvalVARENICLINE TARTRATE

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →VARENICLINE TARTRATE →fda approvals ↗
›Oct 29, 2025approval290d agoLIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalcemiplimab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS

full page →cemiplimab →fda approvals ↗
›Oct 29, 2025approval290d agoLOSARTAN POTASSIUM — FDA approvalLOSARTAN POTASSIUM

Sponsor: GRANULES. Form: TABLET. Route: ORAL

full page →LOSARTAN POTASSIUM →fda approvals ↗
›Oct 29, 2025recall290d agoGraviti Pharmaceuticals Private Limited recall (Cls II)Graviti Pharmaceuticals Inc

Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03. — Reason: Failed Tablet/Capsule Specifications — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoLannett Company Inc. recall (Cls II)Lannett Co Inc

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46 — Reason: Failed Dissolution Specifications — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoThe Harvard Drug Group LLC recall (Cls II)Almatica Pharma LLC

Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61 (Blister pack), NDC 55154-3363-0 (Outer Bag). — Reason: Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoJB Chemicals and Pharmaceuticals Ltd recall (Cls III)Island Pharmaceuticals Ltd

Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10. — Reason: Tablet/Capsules Imprinted with Wrong ID — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoibspot recall (Cls II)

Taoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N — Reason: Marketed Without an Approved NDA/ANDA — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoUSV Private Limited recall (Cls II)SOLA Pharmaceuticals Inc

Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05 — Reason: Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit. — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoMedline Industries, LP recall (Cls II)

Medline, Alcohol Prep Pads (2-Ply Pad, 70% Isopropyl Alcohol), 100 eaches per box, 10 boxes per case (1,000 eaches per case), Single Use Only, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL, 60093 USA, NDC 55329-811-30. — Reason: Subpotent Drug — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoThe Harvard Drug Group LLC recall (Cls II)Almatica Pharma LLC

Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61 — Reason: Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity . — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoJB Chemicals and Pharmaceuticals Ltd recall (Cls III)Island Pharmaceuticals Ltd

Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50 — Reason: Tablet/Capsules Imprinted with Wrong ID — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoChurch & Dwight Co., Inc. recall (Cls II)CHURCH & DWIGHT CO INC /DE/

ZICAM" MEDICATED FRUIT DROPS ELDERBERRY FLAVOR, 25-drops per bottle, Distributed by: Church & Dwight Co., Inc. Ewing, NJ 08628, NDC 10237-469-25 — Reason: Labeling: Label Mix-up: The product in the bottle contains elderberry and the label failed to indicate the inclusion of elderberry as an ingredient. — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoAspiro Pharma Limited recall (Cls II)Aspiro Pharma Ltd

Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label). — Reason: Presence of Particulate Matter: Particulate matter identified as glass — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025recall290d agoBristol-Myers Squibb Company recall (Cls II)BRISTOL MYERS SQUIBB CO

Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11 — Reason: Lack of Assurance of Sterility. — Status: Ongoing

full page →fda recalls ↗
›Oct 29, 2025device 510k290d agoGE Medical Systems Ultrasound and Primary Care Diagnostics — LOGIQ E10 (510k cleared)

Product code: IYN. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoHuxley Medical — SANSA HSAT (510k cleared)

Product code: MNR. Advisory committee: Anesthesiology. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoWright Medical Technology, Inc. (Stryker Corporation) — Synchfix EVT (510k cleared)

Product code: HTN. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoGE Medical Systems Ultrasound and Primary Care Diagnostics — LOGIQ E10s (510k cleared)

Product code: IYN. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoInari Medical — Protrieve Sheath (510k cleared)

Product code: QEW. Advisory committee: Cardiovascular. Type: Special

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoMedtronic, Ireland — Telescope Guide Extension Catheter (510k cleared)

Product code: DQY. Advisory committee: Cardiovascular. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoSmith & Nephew, Inc. — AETOS Shoulder System Meta Humeral Prosthesis Size 0 (510k cleared)SMITH & NEPHEW PLC

Product code: KWS. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoOd-Os GmbH — Navilas Laser System 577sl (156691) (510k cleared)

Product code: HQF. Advisory committee: Ophthalmic. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoFissiontech, LLC — Difiney Advanced Anti Snoring Device 4.0 (510k cleared)

Product code: LRK. Advisory committee: Dental. Type: Special

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoABBOTT MEDICAL — Seguin Annuloplasty Ring (510k cleared)

Product code: KRH. Advisory committee: Cardiovascular. Type: Special

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoShenzhen Beacon Display Technology Co., Ltd. — LCD Monitor (C1216W, C822W, C821W) (510k cleared)

Product code: PGY. Advisory committee: Radiology. Type: Special

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoShenzhen Root Innovation Technology Co., Ltd. — Momcozy Wearable Breast Pump (Model: BP334-, BP380-, BP420-, BP431-, BP400-, BP432-, BP434-) (510k cleared)Hang Feng Technology Innovation Co., Ltd.

Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Special

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoArthrex, Inc. — Arthrex SutureTak Suture Anchor (510k cleared)

Product code: MBI. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoMaxx Orthopedics, Inc. — Freedom Infinia™ Total Knee System (510k cleared)

Product code: JWH. Advisory committee: Orthopedic. Type: Special

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoOrtho-Clinical Diagnostics, Inc. — VITROS Immunodiagnostic Products hs Troponin I Reagent Pack (510k cleared)

Product code: MMI. Advisory committee: Clinical Chemistry. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoSu-Ko Technologies, LLC — SER Pen Carain MicroSystem (MP1209SP) (510k cleared)

Product code: QAI. Advisory committee: General, Plastic Surgery. Type: Special

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoGuangdong Optomedic Technologies, Inc. — 3D Laparoscope (510k cleared)

Product code: GCJ. Advisory committee: Gastroenterology, Urology. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoFH Industrie — JARVIS Diaphyseal Stem Standard (510k cleared)

Product code: PHX. Advisory committee: Orthopedic. Type: Special

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoMeduloc, LLC — Meduloc Intramedullary Fracture Fixation (IFF) System (510k cleared)

Product code: JDW. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device 510k290d agoYa-Man, Ltd. — Medi Lift Essential Eye Mask (510k cleared)

Product code: NFO. Advisory committee: Neurology. Type: Traditional

full page →fda device 510k ↗
›Oct 29, 2025device pma290d agoPremia Spine, Ltd. — TOPS™ System (PMA supplement)

Supplement type: 30-Day Notice. Product code: QWK. Advisory committee: OR. Decision: OK30

full page →fda device pma ↗
← prev
page 1 of 4
next →
$AMRX18.15+5.10%
$HCWB
$LBRX47.77+7.92%
$MRK135.84+0.21%
$ILPLF
$ILPLF
$CHD101.30+0.28%
$MRK135.84+0.21%
$REGN803.48-0.31%
$ABVC
$BMY63.83-1.27%
$FOFO3.0000+2.39%
$SNN29.81-1.00%